[{"from": "human", "value": "Provide a description of this molecule. [C][C][=Branch1][C][=C][C@@H1][C][C][C@][Branch2][=Branch1][Ring1][C@H1][Ring1][Branch1][C@H1][C][C][C@@H1][C@][Branch2][Branch1][#Branch1][C][C][C@@H1][Branch2][Ring1][#C][C][Branch2][Ring1][#Branch1][C@@H1][Ring1][=Branch1][C][C][C@][Ring1][#Branch2][Branch1][N][C@@][Ring1][=C][Branch1][=Branch1][C][C][Ring2][Ring1][C][C][C][Branch1][C][C][C][O][C][=Branch1][C][=O][C][C][Branch1][C][C][Branch1][C][C][C][=Branch1][C][=O][O][C][C][=Branch1][C][=O][O]"}, {"from": "gpt", "value": "The molecule is a pentacyclic triterpenoid obtained by the formal condensation of 2,2-dimethylsuccinic acid with the 3-hydroxy group of betulinic acid. It is isolated from the Chinese herb Syzygium claviflorum. The first in the class of HIV-1 maturation inhibitors to be studied in humans, bevirimat was identified as a potent HIV drug candidate and several clinical trials were conducted, but development into a new drug was plagued by numerous resistance-related problems. It has a role as a metabolite and a HIV-1 maturation inhibitor. It is a pentacyclic triterpenoid, a dicarboxylic acid monoester and a monocarboxylic acid. It is functionally related to a betulinic acid."}]